Characteristics Associated With Recruitment and Re-contact in Mayo Clinic Biobank

Objective: To better understand the characteristics associated with a participant's willingness to consent to the Mayo Clinic Biobank (MCB) and examine factors associated with willingness to participate in follow-up studies embedded within MCB that require re-contact and participant approval.Pa...

Full description

Bibliographic Details
Main Authors: Matthew A. Hathcock, Christine Kirt, Euijung Ryu, Josh Bublitz, Ruchi Gupta, Liwei Wang, Stephen N. Thibodeau, Nicole L. Larson, Mine S. Cicek, James R. Cerhan, Janet E. Olson
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fpubh.2020.00009/full
_version_ 1819266256385081344
author Matthew A. Hathcock
Christine Kirt
Euijung Ryu
Josh Bublitz
Ruchi Gupta
Liwei Wang
Stephen N. Thibodeau
Nicole L. Larson
Mine S. Cicek
James R. Cerhan
Janet E. Olson
author_facet Matthew A. Hathcock
Christine Kirt
Euijung Ryu
Josh Bublitz
Ruchi Gupta
Liwei Wang
Stephen N. Thibodeau
Nicole L. Larson
Mine S. Cicek
James R. Cerhan
Janet E. Olson
author_sort Matthew A. Hathcock
collection DOAJ
description Objective: To better understand the characteristics associated with a participant's willingness to consent to the Mayo Clinic Biobank (MCB) and examine factors associated with willingness to participate in follow-up studies embedded within MCB that require re-contact and participant approval.Participants and Methods: Consent rates were compared across patient demographics to the MCB. Rates of participation to follow-up studies were also compared across demographics and request types.Results: Among 272,102 Mayo Clinic patients invited to the MCB, 48,314 (19%) consented across the three recruitment sites within 90 days of initial invitation. A significant age by gender interaction was identified, showing young males consent at a lower rate than young females and older males consent at a higher rate than older females. Over the recruitment time frame of 2009–2015, there was a significant decrease in consent rates (decline of 2.5%/year). Of the 57,041 consented MCB participants, 33,487 participants (59%) have been invited to participate in follow-up studies via re-contact. Follow-up studies of the MCB may require participants to provide additional samples, complete questionnaires, and/or release their identity to a research team. MCB participants have been invited to enroll in a median of two studies (IQR: 1–3). Seventy-one percent of participants consented to at least one follow-up study, with individual follow-up study consent rates ranging from 14 to 87% depending on study type, with a median consent rate of 61% (IQR: 47–70%). Studies requesting return of a questionnaire had the highest participation rates. White participants, older participants, and participants with some college or a degree were significantly more likely to participate to follow-up studies, while there was no association with gender.Conclusion: Consent rates among younger and non-white patients were lower than in older, white patients. However, we also found that participation rates among those already enrolled in the biobank were much higher than those seen in new recruitment efforts, external to an existing biobank. We thus demonstrate an important way that biobanks can advance precision medicine goals: through provision of populations from which studies can draw participants for future studies.
first_indexed 2024-12-23T20:58:23Z
format Article
id doaj.art-f373a35bb099415383eed3f43d831d90
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-12-23T20:58:23Z
publishDate 2020-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-f373a35bb099415383eed3f43d831d902022-12-21T17:31:28ZengFrontiers Media S.A.Frontiers in Public Health2296-25652020-02-01810.3389/fpubh.2020.00009509141Characteristics Associated With Recruitment and Re-contact in Mayo Clinic BiobankMatthew A. Hathcock0Christine Kirt1Euijung Ryu2Josh Bublitz3Ruchi Gupta4Liwei Wang5Stephen N. Thibodeau6Nicole L. Larson7Mine S. Cicek8James R. Cerhan9Janet E. Olson10Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United StatesDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United StatesDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United StatesDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United StatesDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United StatesDivision of Digital Health Sciences, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United StatesDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United StatesDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United StatesDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United StatesDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United StatesDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, United StatesObjective: To better understand the characteristics associated with a participant's willingness to consent to the Mayo Clinic Biobank (MCB) and examine factors associated with willingness to participate in follow-up studies embedded within MCB that require re-contact and participant approval.Participants and Methods: Consent rates were compared across patient demographics to the MCB. Rates of participation to follow-up studies were also compared across demographics and request types.Results: Among 272,102 Mayo Clinic patients invited to the MCB, 48,314 (19%) consented across the three recruitment sites within 90 days of initial invitation. A significant age by gender interaction was identified, showing young males consent at a lower rate than young females and older males consent at a higher rate than older females. Over the recruitment time frame of 2009–2015, there was a significant decrease in consent rates (decline of 2.5%/year). Of the 57,041 consented MCB participants, 33,487 participants (59%) have been invited to participate in follow-up studies via re-contact. Follow-up studies of the MCB may require participants to provide additional samples, complete questionnaires, and/or release their identity to a research team. MCB participants have been invited to enroll in a median of two studies (IQR: 1–3). Seventy-one percent of participants consented to at least one follow-up study, with individual follow-up study consent rates ranging from 14 to 87% depending on study type, with a median consent rate of 61% (IQR: 47–70%). Studies requesting return of a questionnaire had the highest participation rates. White participants, older participants, and participants with some college or a degree were significantly more likely to participate to follow-up studies, while there was no association with gender.Conclusion: Consent rates among younger and non-white patients were lower than in older, white patients. However, we also found that participation rates among those already enrolled in the biobank were much higher than those seen in new recruitment efforts, external to an existing biobank. We thus demonstrate an important way that biobanks can advance precision medicine goals: through provision of populations from which studies can draw participants for future studies.https://www.frontiersin.org/article/10.3389/fpubh.2020.00009/fullbiobanksconsentparticipationrecruitmentfollow-up study
spellingShingle Matthew A. Hathcock
Christine Kirt
Euijung Ryu
Josh Bublitz
Ruchi Gupta
Liwei Wang
Stephen N. Thibodeau
Nicole L. Larson
Mine S. Cicek
James R. Cerhan
Janet E. Olson
Characteristics Associated With Recruitment and Re-contact in Mayo Clinic Biobank
Frontiers in Public Health
biobanks
consent
participation
recruitment
follow-up study
title Characteristics Associated With Recruitment and Re-contact in Mayo Clinic Biobank
title_full Characteristics Associated With Recruitment and Re-contact in Mayo Clinic Biobank
title_fullStr Characteristics Associated With Recruitment and Re-contact in Mayo Clinic Biobank
title_full_unstemmed Characteristics Associated With Recruitment and Re-contact in Mayo Clinic Biobank
title_short Characteristics Associated With Recruitment and Re-contact in Mayo Clinic Biobank
title_sort characteristics associated with recruitment and re contact in mayo clinic biobank
topic biobanks
consent
participation
recruitment
follow-up study
url https://www.frontiersin.org/article/10.3389/fpubh.2020.00009/full
work_keys_str_mv AT matthewahathcock characteristicsassociatedwithrecruitmentandrecontactinmayoclinicbiobank
AT christinekirt characteristicsassociatedwithrecruitmentandrecontactinmayoclinicbiobank
AT euijungryu characteristicsassociatedwithrecruitmentandrecontactinmayoclinicbiobank
AT joshbublitz characteristicsassociatedwithrecruitmentandrecontactinmayoclinicbiobank
AT ruchigupta characteristicsassociatedwithrecruitmentandrecontactinmayoclinicbiobank
AT liweiwang characteristicsassociatedwithrecruitmentandrecontactinmayoclinicbiobank
AT stephennthibodeau characteristicsassociatedwithrecruitmentandrecontactinmayoclinicbiobank
AT nicolellarson characteristicsassociatedwithrecruitmentandrecontactinmayoclinicbiobank
AT minescicek characteristicsassociatedwithrecruitmentandrecontactinmayoclinicbiobank
AT jamesrcerhan characteristicsassociatedwithrecruitmentandrecontactinmayoclinicbiobank
AT janeteolson characteristicsassociatedwithrecruitmentandrecontactinmayoclinicbiobank